NM_001369.3(DNAH5):c.12171T>C (p.Asp4057=) AND Primary ciliary dyskinesia

Germline classification:: Likely benign (2 submissions)
Last evaluated:: Jan 11, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001454546.9

Allele description [Variation Report for NM_001369.3(DNAH5):c.12171T>C (p.Asp4057=)]

NM_001369.3(DNAH5):c.12171T>C (p.Asp4057=)

Gene:

DNAH5:dynein axonemal heavy chain 5 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

5p15.2

Genomic location:

Preferred name:

NM_001369.3(DNAH5):c.12171T>C (p.Asp4057=)

HGVS:

NC_000005.10:g.13721108A>G
NG_013081.2:g.228373T>C
NM_001369.3:c.12171T>CMANE SELECT
NP_001360.1:p.Asp4057=
NC_000005.9:g.13721217A>G
NM_001369.2:c.12171T>C
NM_001369.3:c.12171T>C

Links:

dbSNP: rs181510043

NCBI 1000 Genomes Browser:

rs181510043

Molecular consequence:

NM_001369.3:c.12171T>C - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: Primary ciliary dyskinesia
Synonyms:: Ciliary dyskinesia
Identifiers:: MONDO: MONDO:0016575; MedGen: C0008780; OMIM: PS244400; Human Phenotype Ontology: HP:0012265

Recent activity

Clear Turn Off Turn On

Verrucomicrobia bacterium SCGC AAA204-E03 16S ribosomal RNA gene, partial sequen...
Verrucomicrobia bacterium SCGC AAA204-E03 16S ribosomal RNA gene, partial sequence
gi|336110658|gb|JF488111.1|

Nucleotide
Homo sapiens ubiquitin conjugating enzyme E2 B (UBE2B), mRNA
Homo sapiens ubiquitin conjugating enzyme E2 B (UBE2B), mRNA
gi|1653961337|ref|NM_003337.4|

Nucleotide
Homo sapiens serpin family D member 1 (SERPIND1), mRNA
Homo sapiens serpin family D member 1 (SERPIND1), mRNA
gi|1519244598|ref|NM_000185.4|

Nucleotide
inositol polyphosphate-4-phosphatase type I A isoform a [Homo sapiens]
inositol polyphosphate-4-phosphatase type I A isoform a [Homo sapiens]
gi|4755140|ref|NP_004018.1|

Protein
LOC101928177 [Homo sapiens]
LOC101928177 [Homo sapiens]
Gene ID:101928177

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001658275	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely benign (Jan 11, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV002661345	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Likely benign (Nov 17, 2019)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001658275

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely benign
(Jan 11, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002661345

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Likely benign
(Nov 17, 2019)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001658275.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Ambry Genetics, SCV002661345.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine